JCR PHARMACEUTICALS CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 808 JPY | -0.37% |
|
-1.94% | -31.06% |
| Mar. 21 | US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak | MT |
| Mar. 21 | JCR Pharmaceuticals Achieves Neurodegenerative Treatment Research Milestone With Alexion | MT |
Chart calendar JCR Pharmaceuticals Co., Ltd.
59f50d0bc85640.jZy2_iLcFYnuWKHsoGwqFTT3e3MbdqliFkbBmkyCOvE.y-bekWaKLPG8GdDU7DljWG2WOD9SJ8Y9JB6r1jm6f5vIxcXMR5st5d0q8A~49096e98032e60c71df78e2eef4c0c8e
Upcoming events on JCR Pharmaceuticals Co., Ltd.
Past events on JCR Pharmaceuticals Co., Ltd.
| 2024-03-27 | Final dividend |
| 2024-02-03 | WORLD Symposium |
| 2024-01-25 | Q3 2023 Earnings Release |
| 2023-10-24 | Q2 2023 Earnings Release |
| 2023-10-03 10:00 pm | JR-171 Phase I/II Study Results Call |
| 2023-09-27 | Ex-dividend day for dividende intermédiaire |
| 2023-07-25 | Q1 2023 Earnings Release |
| 2023-05-10 | Q4 2022 Earnings Release |
| 2023-03-29 | Ex-dividend day for final dividend |
| 2023-01-30 | Q3 2022 Earnings Release |
| 2022-10-25 | Interim 2022 Earnings Release |
| 2022-09-28 | Ex-dividend day for dividende intermédiaire |
| 2022-07-26 | Q1 2022 Earnings Release |
| 2022-05-11 | FY 2021 Earnings Release |
| 2022-03-29 | Ex-dividend day for final dividend |
| 2022-02-10 06:00 pm | WORLD Symposium - Poster No - 205 |
| 2022-02-10 06:00 pm | WORLD Symposium - Poster No - 89 |
| 2022-02-09 06:00 pm | WORLD Symposium - Poster No - 135 |
| 2022-02-09 06:00 pm | WORLD Symposium - Poster No - 113 |
| 2022-02-09 06:00 pm | WORLD Symposium - Poster No - 289 |
Past dividends on JCR Pharmaceuticals Co., Ltd.
| 2024-03-27 | Final Payment 10 JPY |
| 2023-09-27 | Interim Payment 10 JPY |
| 2023-03-29 | Final Payment 10 JPY |
| 2022-09-28 | Interim Payment 10 JPY |
| 2022-03-29 | Bonus Payment 2 JPY |
| 2022-03-29 | Final Payment 10 JPY |
| 2021-09-28 | Interim Payment 10 JPY |
| 2021-03-29 | Bonus Payment 0.5 JPY |
| 2021-03-29 | Final Payment 7 JPY |
| 2020-09-28 | Interim Payment 18 JPY |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 23 160 22 650 2.25% | 24 781 25 470 -2.71% | 30 085 27 769 8.34% | 51 082 49 841 2.49% | 34 343 38 989 -11.92% | 45 366 |
|
EBITDA Million JPY | Released Forecast Spread | 6 310 5 961 5.86% | 4 678 5 564 -15.92% | 10 161 8 476 19.88% | 21 878 24 774 -11.69% | 6 972 11 924 -41.53% | 12 432 |
|
EBIT Million JPY | Released Forecast Spread | 4 967 4 710 5.46% | 3 244 4 109 -21.05% | 8 269 6 830 21.07% | 19 933 22 768 -12.45% | 4 975 10 210 -51.27% | 10 386 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 4 928 4 855 1.5% | 3 422 3 962 -13.63% | 8 653 6 773 27.75% | 19 404 22 522 -13.84% | 5 412 9 469 -42.84% | 9 900 |
|
Net income Million JPY | Released Forecast Spread | 3 715 3 528 5.32% | 2 678 3 322 -19.4% | 6 892 5 400 27.64% | 14 507 15 578 -6.87% | 3 772 7 575 -50.2% | 7 245 |
|
EPS JPY | Released Forecast Spread | 30,2 28,2 7.15% | 21,7 26,5 -18.08% | 55,8 43,8 27.32% | 117 126 -6.91% | 30,4 61,1 -50.31% | 58,2 |
| Announcement Date | 10/05/19 | 12/05/20 | 13/05/21 | 12/05/22 | 11/05/23 | - |
Quarterly results
| Fiscal Period | March | 2020 S1 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 11 236 10 509 6.92% | 10 951 | 19 134 17 299 10.61% | 28 383 | 11 887 | 10 812 12 250 -11.74% | 22 699 24 247 -6.38% | 9 606 9 430 1.87% | 5 975 8 278 -27.82% | 15 581 | 11 115 10 696 3.92% | 7 647 8 627 -11.35% | 18 762 18 909 -0.78% | 10 808 | 13 464 11 000 22.4% | 24 272 | 9 446 13 000 -27.34% | 12 382 | 22 628 |
|
EBIT Million JPY | Released Forecast Spread | 998 824 21.12% | 1 307 | 6 962 3 630 91.79% | 13 640 | 4 716 | 1 577 4 295 -63.28% | 6 293 8 800 -28.49% | 1 536 3 286 -53.26% | -792 1 196 -166.25% | 744 | 4 209 6 418 -34.42% | 22,0 1 106 -98.01% | 4 231 5 072 -16.58% | 2 066 | 4 832 2 800 72.57% | 6 898 | 911 3 400 -73.21% | 3 066 | 4 252 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 1 098 824 33.25% | 1 381 | 7 272 6 055 20.1% | 12 729 | 4 993 | 1 682 4 176 -59.72% | 6 675 9 169 -27.2% | 2 083 | 1 560 | 3 720 | 132 1 425 -90.74% | 3 852 5 145 -25.13% | 2 260 | 7 120 | 251 | 3 162 | 3 413 | ||
|
Net income Million JPY | Released Forecast Spread | 922 666 38.44% | 1 227 | 5 665 4 503 25.81% | 9 234 | 3 687 | 1 586 3 069 -48.32% | 5 273 6 756 -21.95% | 1 368 | -406 945 -142.96% | 962 | 2 606 | 204 1 452 -85.95% | 2 810 4 058 -30.75% | 1 610 | 3 643 2 000 82.15% | 5 253 | -93,0 2 400 -103.88% | 2 380 | 2 627 |
|
EPS JPY | Released Forecast Spread | 7,49 | 9,94 | 45,9 36,5 25.67% | 74,7 | 29,8 | 12,8 24,8 -48.35% | 42,6 54,6 -21.98% | 11,1 | -3,29 7,60 -143.29% | 7,77 | 21,0 | 1,62 6,80 -76.18% | 22,6 32,5 -30.52% | 12,9 | 29,2 16,0 82.12% | 42,1 | -0,75 11,4 -106.59% | 16,7 | |
| Announcement Date | 31/10/19 | 26/10/20 | 13/05/21 | 28/10/21 | 27/01/22 | 12/05/22 | 12/05/22 | 27/07/22 | 26/10/22 | 26/10/22 | 31/01/23 | 11/05/23 | 11/05/23 | 26/07/23 | 25/10/23 | 25/10/23 | 26/01/24 | - | - |
More events
Past sector events for JCR Pharmaceuticals Co., Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4552 Stock
- Calendar JCR Pharmaceuticals Co., Ltd.
